In order to study the role of STAT5in IL-3 signaling, and to find new growth inhibitors of leukaemic cells, we have screened inhibitors of STAT5from microbial metabolites using a luciferase reporter system in IL-3 dependent Ba/F3 cells. The cells were transfected with reporter plasmid consisting of luciferase gene under the control of the jS-casein promoter having STAT5 binding sites. In this system, the expression of the luciferase MAY 1997 activity is expected to be suppressed by inhibitors of JAK-STAT signal transduction.
In thp course of our screening program using this system, we have found a new compound, cytovaricin B
(1) from the culture broth of Streptomyces torulosus 3197-GM1. In this paper, we report the fermentation, isolation, physico-chemical properties, structure elucidation and inhibitory activity of 1.
Streptomyces torulosus 3 197-GM1, which was isolated from a soil sample collected in Iwaki, Fukushima
Prefecture, Japan, was inoculated in 500-ml Erlenmeyer flasks containing 100ml of a medium comprising of starch 2.5%, soybean meal 1.5%, dry yeast 0.2%, and
CaCO3 0.4%, the pH being adjusted to 6.2 before sterilization.
The fermentation was carried out at 27°C for 5 days on a rotary shaker. The supernatant of cultured broth (1.6liter) was extracted twice with ethyl acetate (1 liter x 2) at pH 7. The organic layer was concentrated to dryness and the residue was applied to a silica gel column (2 x 30cm, Wakogel C-200). After washing the column with hexane (200ml), the active material was eluted with hexane-ethyl acetate (3: 1, 300ml) and w-hexane-ethyl acetate (2: 1, 300ml). The combined active eluate was concentrated to give a crude material, which was subjected to Toyopearl HW-40 column (2 x 70 cm) chromatography using 80%aqueous acetone as the developing solvent. The active fractions were further purified by reversed phase HPLC, using a column of YMCPack ODS (2x 25cm, flow rate 5ml/minute) with elution using 65%aqueous acetonitrile to give two fractions. The fraction containing 1 was evaporated in vacuo to give 8.0mg of pure 1 as a colorless amorphous powder, and the other fraction yielded a colorless powder (10.2 mg) of cytovaricin (2)1(U 1). Physico-chemical properties of 1 are summarized in Table 1 . 1 was soluble in CHC13, EtOAc, Me2CO, MeOH and DMSO, but insoluble in w-hexane and H2O. The molecular formula of 1 was established as C48H82O16 from the HRFAB-MSand NMRspectral analyses. The IR spectrum of 1 showed the presence of an a,/?-unsaturated ester at 1720cm" 1. NMRdata of 1 are summarized in Table 2 . The structure of1 was determined by the analyses of DQF-COSY, HMQCand HMBC spectral data. All assignments were made based on comparison with 2. An additional methoxy proton (17-OMe, 3.20ppm) only observed in 1 was long-range coupled to a quaternary carbon C-17 (101.1 ppm) in the HMBCspectrum of 1. Therefore, the tertiary hydroxyl group at C-17 in 2 is concluded to be substituted by a methoxy group in 1. Thus, the structure of 1 was established as a lactol methyl ether of 2. In order to determine the stereochemistry of 1, 2 was treated with methanol in the presence of Dowex 50 (H+) at 0°C for 2 hours to give a lactol methyl ether of212). Comparison of the spectral data for the purified product from the reaction mixture and 1 showed complete agreement.
Thus, the structure including the absolute stereochemistry of 1 was determined as shown in Fig. 1 . Since the purification of 1 from the cultured broth was made in the absence of methanol, 1 is believed to be a natural product isolated from the nature for the first time.
The inhibitory effect of 1 in our system used for the screening was 32 fim (IC50). 2 was also active at the same concentration.
In the evaluation system we employed3'4'1 31, 1 directly inhibited STAT5 phosphorylation in naive Ba/F3 cells without affecting JAK2 phosphorylation. Further studies on the mechanism of 
